The Pharma Data

SEPTEMBER 29, 2020

. Sosei Heptares has received a $5m milestone payment from its strategic alliance partner Pfizer after the first subject in a clinical trial was dosed with a new drug candidate from the collaboration between the two companies.

Structure Based Drug Design (SBDD) 52

Structure Based Drug Design (SBDD) Clinical Trials Small Molecule Pharma Companies 52

PPD

JULY 13, 2023

Site and patient recruitment vendors are vital in supporting clinical trial operations across all phases and therapeutic areas. Their services help engage a suitable participant pool, facilitate clinical trial participation, ensure that selected sites have the resources to support clinical trial activities and more.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Clinical Research 52

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. The Ampligen EAP protocol is authorized to enroll up to 100 active trial participants, 20 of whom may be Long Haulers. Centers for Disease Control and Prevention’s criteria for chronic fatigue syndrome. See: PLOS ONE ).

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52

H1 Blog

JULY 30, 2024

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. We’re curious to see what will happen over the next 12 months and how pharma companies will respond.”

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

The Pharma Data

SEPTEMBER 11, 2020

While stories from news outlets indicate the peak of the infection has passed in most European countries, cases of the disease continue to rise in other parts of the world, especially Latin America and Africa. This week’s round up dives into developments from companies based in Australia and the US. “The Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Pharma Companies Trials Hospitals 52

Codon

FEBRUARY 13, 2024

alone, according to the Centers for Disease Control and Prevention. 1 Yet even after more than two decades of research, media hype, and dozens of clinical trials and biotech start-ups that have come and gone, phage therapy has not scaled. At least a million people die from drug-resistant bacterial infections every year.

Therapies 124

Therapies Virus DNA Clinical Trials 124

Vial

DECEMBER 8, 2023

In this article by Vial CRO (Contract Research Organization), we will explore five anticipated ophthalmology therapies in 2024, offering valuable insights for biotech startups, CROs, pharma companies, clinical sites, and scientists planning to conduct clinical trials.

Therapies 52

Therapies Clinical Trials Trials Treatment 52

The Pharma Data

JANUARY 17, 2021

Alzheimer’s disease has found itself in the top three most expensive diseases. This week another biopharma announced the disappointing news that their trial too had failed to make an impact on the devastating progression of Alzheimer’s. The trial found that troriluzole was well tolerated at the 280 mg dose.

Pharma Companies 52

Pharma Companies Disease Treatment Trials 52

H1 Blog

JULY 5, 2023

The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. African Americans).

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

The Open Targets Blog

OCTOBER 24, 2023

OMass Therapeutics is using a new technology platform to develop treatments for rare immunological and genetic diseases with high unmet patient needs. We primarily work on immune system diseases, integrating data and analyses from OTG on a large scale. Genetics is at the heart of our target selection pipeline.

Bioinformatics 63

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 63

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … The Perceptron was designed to improve the accuracy of computer predictions.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

The Pharma Data

OCTOBER 20, 2020

In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. 2 killer in America, just behind heart disease. Cancer is still the No.

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

Vial

MARCH 1, 2024

Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market. By geographical region, the global CRO services market in 2023 was dominated by North America.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

The Pharma Data

DECEMBER 11, 2020

The University of Oxford has regularly appeared in our updates since July 2020, as its team of researchers leads an ongoing clinical trial for the Covid-19 vaccine. More recently, the university has released news of its collaboration with Thermo Fisher Scientific as it looks to discover an immune Covid-19 response pre- and post-vaccination.

Vaccine 52

Vaccine Immune Response Pharma Companies Virus 52

Advarra

JULY 19, 2022

The sponsor is the pharmaceutical company conducting the trial. If you mean using a different contract research organization (CRO) for the different phases of clinical trials – that’s different. Also consider CRO oversight, trial management, data handling and record keeping, as well as allocation of responsibilities.

Packaging 52

Packaging FDA Trials Regulations 52

The Anticancer Fund

JUNE 7, 2022

This is another study that is strongly supportive of replication and further development, including clinical trial development. In both newly diagnosed and recurrent PDX models the drug was shown to be non-toxic and to have meaningful anti-GBM activity - including a survival benefit.

Clinical Trials 40

Clinical Trials Drugs Trials Treatment 40

Vial

FEBRUARY 19, 2024

As we put it in first in human (trials), and we saw responses, it was super exciting to be able to navigate the landscape and where to position it for the patient benefit. At the time, chronic lymphocytic leukemia was really a horrible disease, and only 57 percent of patients had a response. BTK made a difference.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

H1 Blog

DECEMBER 11, 2024

These forecasts highlight the key changes poised to transform the healthcare and pharma landscapes. In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Additionally, well see a move to multi-indication trials to maximize profitability.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

The Pharma Data

OCTOBER 14, 2020

VBL has recently demonstrated ex-vivo activity of anti-MOSPD2 antibodies in patients with relapsing-remitting and progressive multiple sclerosis (MS), as well as in animal models of rheumatoid arthritis (RA), nonalcoholic steatohepatitis (NASH) and inflammatory bowel disease (IBD). Inventiva – The U.S. adults age 65 and older.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Therapies 52

The Pharma Data

NOVEMBER 16, 2020

The “polypill” containing three generic blood pressure medications and a statin dramatically reduced the risk of heart-related illness in people with no prior history of heart problems, according to clinical trial results. For the trial, more than 5,700 people from nine countries were randomly assigned to one of four groups.

Health Insurance Companies 52

Health Insurance Companies Doctors Medical Schools Pharma Companies 52

Altus Drug Development

JUNE 28, 2022

Drug repositioning has become a strategic research approach when treating neglected diseases. This is due to 5 main reasons: The required clinical trial steps of a repurposed medicine are fewer than normal. The cost of drug development varies with the disease, with cancer drugs being the most expensive to develop ( source ).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. A piece of technology, originally designed to be used on plants, had medical implications for humans here on earth to treat illness, disease and pain. It’s all about the bottom line, at any cost.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

The Pharma Data

DECEMBER 30, 2020

In September 2020, the trials were halted to investigate a potentially severe side effect in a UK patient, transverse myelitis, an inflammation of part of the spinal cord. After a short break, the trial restarted in the UK and other parts of the world, but was delayed for much longer in the U.S. Biogen’s aducanumab.

Vaccine 52

Vaccine FDA Trials Therapies 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … The Perceptron was designed to improve the accuracy of computer predictions.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

Drug Target Review

MARCH 13, 2025

Negative data is often much larger in size than published data because it includes raw data from failed experiments, clinical trials with no significant effect and studies with null results. Techbio companies have initiated this approach. Although AI models have shown great potential, their generalisation capacity is still limited.

Drug Development 52

Drug Development Science Clinical Trials FDA 52